GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sigma Healthcare Ltd (OTCPK:SIGGF) » Definitions » Gross Margin %

Sigma Healthcare (Sigma Healthcare) Gross Margin % : 9.54% (As of Jan. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sigma Healthcare Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Sigma Healthcare's Gross Profit for the six months ended in Jan. 2024 was $107 Mil. Sigma Healthcare's Revenue for the six months ended in Jan. 2024 was $1,124 Mil. Therefore, Sigma Healthcare's Gross Margin % for the quarter that ended in Jan. 2024 was 9.54%.

Warning Sign:

Sigma Healthcare Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.6%.


The historical rank and industry rank for Sigma Healthcare's Gross Margin % or its related term are showing as below:

SIGGF' s Gross Margin % Range Over the Past 10 Years
Min: 6.89   Med: 8.13   Max: 8.93
Current: 8.05


During the past 13 years, the highest Gross Margin % of Sigma Healthcare was 8.93%. The lowest was 6.89%. And the median was 8.13%.

SIGGF's Gross Margin % is ranked worse than
79.17% of 96 companies
in the Medical Distribution industry
Industry Median: 16.37 vs SIGGF: 8.05

Sigma Healthcare had a gross margin of 9.54% for the quarter that ended in Jan. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Sigma Healthcare was -1.60% per year.


Sigma Healthcare Gross Margin % Historical Data

The historical data trend for Sigma Healthcare's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sigma Healthcare Gross Margin % Chart

Sigma Healthcare Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.17 8.82 8.43 6.95 8.05

Sigma Healthcare Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.73 8.37 5.48 6.55 9.54

Competitive Comparison of Sigma Healthcare's Gross Margin %

For the Medical Distribution subindustry, Sigma Healthcare's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sigma Healthcare's Gross Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Sigma Healthcare's Gross Margin % falls into.



Sigma Healthcare Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Sigma Healthcare's Gross Margin for the fiscal year that ended in Jan. 2024 is calculated as

Gross Margin % (A: Jan. 2024 )=Gross Profit (A: Jan. 2024 ) / Revenue (A: Jan. 2024 )
=180.4 / 2240.057
=(Revenue - Cost of Goods Sold) / Revenue
=(2240.057 - 2059.665) / 2240.057
=8.05 %

Sigma Healthcare's Gross Margin for the quarter that ended in Jan. 2024 is calculated as


Gross Margin % (Q: Jan. 2024 )=Gross Profit (Q: Jan. 2024 ) / Revenue (Q: Jan. 2024 )
=107.3 / 1124.084
=(Revenue - Cost of Goods Sold) / Revenue
=(1124.084 - 1016.833) / 1124.084
=9.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Sigma Healthcare  (OTCPK:SIGGF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Sigma Healthcare had a gross margin of 9.54% for the quarter that ended in Jan. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Sigma Healthcare Gross Margin % Related Terms

Thank you for viewing the detailed overview of Sigma Healthcare's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sigma Healthcare (Sigma Healthcare) Business Description

Traded in Other Exchanges
Address
2125 Dandenong Road, Level 6, Clayton, Melbourne, VIC, AUS, 3168
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.